Berenberg Bank restated their buy rating on shares of Essentra (LON:ESNT – Free Report) in a research report sent to investors on Thursday, MarketBeat Ratings reports. Berenberg Bank currently has a GBX 200 ($2.60) target price on the stock.
A number of other research analysts also recently weighed in on ESNT. Deutsche Bank Aktiengesellschaft lowered their price target on Essentra from GBX 240 ($3.12) to GBX 200 ($2.60) and set a “buy” rating on the stock in a report on Tuesday, September 17th. Jefferies Financial Group lowered their target price on Essentra from GBX 260 ($3.38) to GBX 250 ($3.25) and set a “buy” rating on the stock in a research note on Friday, July 12th.
View Our Latest Analysis on Essentra
Essentra Price Performance
Essentra Cuts Dividend
The company also recently announced a dividend, which will be paid on Friday, October 25th. Investors of record on Thursday, September 19th will be issued a GBX 1.25 ($0.02) dividend. The ex-dividend date is Thursday, September 19th. This represents a yield of 0.76%.
Insider Transactions at Essentra
In related news, insider Scott Fawcett bought 10,479 shares of the company’s stock in a transaction dated Wednesday, September 18th. The stock was acquired at an average cost of GBX 142 ($1.84) per share, with a total value of £14,880.18 ($19,319.89). Insiders own 0.99% of the company’s stock.
About Essentra
Essentra plc manufactures and distributes plastic injection and vinyl dip moulded, and metal components worldwide. The company offers cable ties and conduit, and accessories; grommets, strain relief, and blanking plugs; cable glands and accessories; caps and plugs; card guides and pullers; circuit board hardware products; EMI suppression ferrite cores; fan accessories comprising filters and fan mounting accessories; screws and nuts; rivet and panel fasteners; barbed and push-fit fasteners; binder screws and snap fasteners; washers; spacers; brushes; feet; fibre management; and furniture fittings.
See Also
- Five stocks we like better than Essentra
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Compound Interest and Why It Matters When Investing
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- The Downtrend in UPS Stock Isn’t Over Yet
Receive News & Ratings for Essentra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Essentra and related companies with MarketBeat.com's FREE daily email newsletter.